Biomarin Pharmaceutical Inc 10-K for FY2022
Biomarin Pharmaceutical Inc (BMRN)
10-K
2023-02-27
For: 2022-12-31
View Original
Added on
April 12, 2026
About this 10-K
Biomarin Pharmaceutical Inc filed this 10-K on February 27, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.1B
- up 13.5% from $1.85B a year earlier
- Net income
- $141.56M
- compared with a net loss of $64.08M a year earlier
- Diluted EPS
- $0.75
- compared with -$0.35 a year earlier